News
Press Release: Veranex Acquires Leading Preclinical Services Provider T3 Labs
Mar 25, 2025
Raleigh, NC, December 14, 2023—Veranex, provider of the first purpose-built, global service platform for the medtech industry, today announced that it has acquired T3 Labs, a highly reputable preclinical laboratory located in Atlanta, Georgia. This acquisition...
Veranex Acquires Leading Pathology and Histology Provider HORUS Scientific
Mar 25, 2025
The addition increases footprint and provides speed, flexibility, and depth of GLP services to North America and the EU. Veranex, the first purpose-built, integrated global service platform for the medtech industry, announced that it has acquired HORUS Scientific, a...
Veranex Appoints Ryan Roberts as Chief Commercial Officer
Mar 25, 2025
RALEIGH, N.C.; 9/18/23, 2023 – Veranex, the only global, tech-enabled product development services provider focused on the medical technology industry, announces the newest addition to their executive team in Chief Commerical Officer, Ryan Roberts. Ryan brings over...
Surmodics Receives FDA 510(k) Clearance for Pounce™ LP Thrombectomy System
Mar 25, 2025
Read the business wire announcement here! June 14, 2023 07:30 AM Eastern Daylight Time EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, announced it has received U.S. Food...
Industry Veterans and Experts Join Veranex Test
Mar 25, 2025
RALEIGH, N.C.; May 24, 2022 – Veranex today announced the expansion of the company’s leadership team with the additions of Patricia Deverka as Senior Vice President, Commercial Strategy & Market Access; Amanda Briscoe as Senior Vice President of Business...
Veranex Joins Industry Leaders as a Sponsor for the Stanford Byers Center for Biodesign
Mar 25, 2025
RALEIGH, N.C.– March 20, 2023 (Business Wire) – Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the medtech industry, today announced that it has joined industry leaders as corporate sponsors for the Stanford Byers Center for...
Veranex Acquires Fusion Biotec to Continue Accelerating MedTech Diagnostic Solutions
Mar 25, 2025
RALEIGH, N.C.; Dec. 13, 2022 (Business Wire) – Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the MedTech industry, announced today that it has acquired Fusion Biotec (Fusion), a design and engineering leader for complex...
Veranex Announces Tom Daulton as CEO and Appointment of David Dockhorn to New COO Role
Mar 25, 2025
RALEIGH, N.C.; Oct. 20, 2022 (Business Wire) – Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the MedTech industry, announced today the appointment of industry veteran Tom Daulton as chief executive officer (CEO). David...
Veranex Acquires Devicia and Clarvin, Expanding Regulatory, Quality, and Clinical Expertise for IVD and Medical Devices
Mar 25, 2025
RALEIGH, N.C.; Oct. 11, 2022 (Business Wire) – Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry, announced today that it has acquired an ecosystem of full-service medical device consultancy...
Veranex Expands European MedTech Capabilities With Acquisition of Medidee
Mar 25, 2025
RALEIGH, N.C.; Sept. 20, 2022 (Business Wire) – Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry, announced today that it has acquired Medidee, a top MedTech consultancy company headquartered in...